Olesen, M. T. J., Walther, R., Poier, P. P., Dagnæs-Hansen, N. F. & Zelikin, A. N. (2020).
Molecular, macromolecular, and supramolecular glucuronide prodrugs: Lead identified for anticancer prodrug monotherapy.
Angewandte Chemie International Edition,
59(19), 7390-7396.
https://doi.org/10.1002/anie.201916124
Østergaard, S. D., Trabjerg, B. B., Als, T. D., Albiñana, C., Privé, F., Vilhjálmsson, B. J., Bækvad-Hansen, M., Bybjerg-Grauholm, J., Hougaard, D. M., Nordentoft, M., Werge, T.
, Demontis, D., Mortensen, P. B., Børglum, A. D., Mors, O. & Agerbo, E. (2020).
Polygenic risk score, psychosocial environment and the risk of attention-deficit/hyperactivity disorder.
Translational Psychiatry,
10(1), Article 335.
https://doi.org/10.1038/s41398-020-01019-6
Paksarian, D.
, Trabjerg, B. B., Merikangas, K. R.
, Mors, O., Børglum, A. D., Hougaard, D. M., Nordentoft, M., Werge, T.
, Pedersen, C. B., Mortensen, P. B., Agerbo, E. & Horsdal, H. T. (2020).
Adolescent residential mobility, genetic liability and risk of schizophrenia, bipolar disorder and major depression.
British Journal of Psychiatry,
217(1), 390-396.
https://doi.org/10.1192/bjp.2020.8Pallesen, L. T., Gustafsen, C., Cramer, J., Petersen, S. V., Thirup, S. S., Madsen, P. & Petersen, C. M. (2020).
PAK kinases targets sortilin and modulates its sorting.
Molecular and Cellular Biology,
40(3), Article e00411-19.
https://doi.org/10.1128/MCB.00411-19
Parbo, P., Madsen, L. S., Ismail, R., Zetterberg, H., Blennow, K.
, Eskildsen, S. F., Vorup-Jensen, T. & Brooks, D. J. (2020).
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
Alzheimer's Research & Therapy,
12(1), Article 3.
https://doi.org/10.1186/s13195-019-0574-0
Park, D., Novak, B., Yan, Y., Kaya, M. E. & Turck, C. W. (2020).
Paroxetine binding and activation of phosphofructokinase implicates energy metabolism in antidepressant mode of action.
Journal of Psychiatric Research,
129, 8-14.
https://doi.org/10.1016/j.jpsychires.2020.05.033
Pedersbæk, D., Jønsson, K., Madsen, D. V., Weller, S.
, Bohn, A. B., Andresen, T. L. & Simonsen, J. B. (2020).
A quantitative: Ex vivo study of the interactions between reconstituted high-density lipoproteins and human leukocytes.
RSC Advances,
10(7), 3884-3894.
https://doi.org/10.1039/c9ra08203dPedersen, M. A., Jensen-Fangel, S., Nielsen, E., Borghammer, P. & Vendelbo, M. H. (2020).
Absent 18F-FDG Uptake in the Brain-Unsuspected Brain Death.
Clinical Nuclear Medicine,
45(10), e433-e434.
https://doi.org/10.1097/RLU.0000000000003237
Pedersen, H., Jensen, R. K., Hansen, A. G., Gadeberg, T. A. F., Thiel, S., Laursen, N. S. & Andersen, G. (2020).
A C3 specific nanobody that blocks all three activation pathways in the human and murine complement system.
The Journal of Biological Chemistry,
295(26), 8746-8758.
https://doi.org/10.1074/jbc.RA119.012339
Pedersen, H., Jensen, R. K., Jensen, J. M. B., Fox, R.
, Pedersen, D. V., Olesen, H. G., Hansen, A. G., Christiansen, D.
, Mazarakis, S. M. M., Lojek, N.
, Hansen, P., Gadeberg, T. A. F., Zarantonello, A., Laursen, N. S., Mollnes, T. E., Johnson, M. B., Stevens, B.
, Thiel, S. & Andersen, G. R. (2020).
A Complement C3-Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity.
Journal of Immunology,
205(8), 2287-2300.
https://doi.org/10.4049/jimmunol.2000752
Pedersen, S. A., Klesse, T.
, Andreasen, M. F., Dalhoff, K. P.
& Andersen, C. U. (2020).
Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence.
Basic and Clinical Pharmacology and Toxicology,
127(5), 438-441.
https://doi.org/10.1111/bcpt.13449Pedersen, J. G., Madsen, A. T., Gammelgaard, K. R., Aggerholm-Pedersen, N., Sørensen, B. S., Øllegaard, T. H. & Jakobsen, M. R. (2020).
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors.
Cancers,
12(6), 1-15. Article 1414.
https://doi.org/10.3390/cancers12061414
Pedersen, D. V., Rösner, T.
, Hansen, A. G., Andersen, K. R., Thiel, S., Andersen, G. R., Valerius, T.
& Laursen, N. S. (2020).
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement.
Molecular Immunology,
124, 200-210.
https://doi.org/10.1016/j.molimm.2020.06.005
Piesche, M., Roos, J., Kühn, B., Fettel, J., Hellmuth, N., Brat, C., Maucher, I. V., Awad, O.
, Matrone, C., Comerma Steffensen, S. G., Manolikakes, G., Heinicke, U., Zacharowski, K. D., Steinhilber, D.
& Maier, T. J. (2020).
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer.
Frontiers in Pharmacology,
11, Article 1297.
https://doi.org/10.3389/fphar.2020.01297
Poulsen, T. B. G., Karamehmedovic, A., Aboo, C., Jørgensen, M. M., Yu, X., Fang, X., Blackburn, J. M., Nielsen, C. H.
, Kragstrup, T. W. & Stensballe, A. (2020).
Protein array-based companion diagnostics in precision medicine.
Expert Review of Molecular Diagnostics,
20(12), 1183-1198.
https://doi.org/10.1080/14737159.2020.1857734Povlsen, A. L., Grimm, D., Wehland, M., Infanger, M. & Krüger, M. (2020).
The Vasoactive Mas Receptor in Essential Hypertension.
Journal of Clinical Medicine,
9(1), Article 267.
https://doi.org/10.3390/jcm9010267
Prasad, B., Richter, P., Vadakedath, N., Mancinelli, R., Krüger, M., Strauch, S. M.
, Grimm, D., Darriet, P., Chapel, J.-P., Cohen, J. & Lebert, M. (2020).
Exploration of space to achieve scientific breakthroughs.
Biotechnology Advances,
43, Article 107572.
https://doi.org/10.1016/j.biotechadv.2020.107572